A surface-independent bioglue using photo-crosslinkable benzophenone moiety.
Yue ShiXuelian TaoPing DuPaul PasicLars EsserHsien-Yeh ChenHelmut ThissenPeng-Yuan WangPublished in: RSC advances (2024)
Surface coating technology is broadly demanded across various fields, including marine and biomedical materials; therefore, a facile and versatile approach is desired. This study proposed an attractive surface coating strategy using photo-crosslinkable benzophenone (BP) moiety for biomaterials application. BP-containing "bioglue" polymer can effectively crosslink with all kinds of surfaces and biomolecules. Upon exposure to ultraviolet (UV) light, free radical reaction from the BP glue facilitates the immobilization of diverse molecules onto different substrates in a straightforward and user-friendly manner. Through either one-step, mixing the bioglue with targeted biomolecules, or two-step methods, pre-coating the bioglue and then adding targeted biomolecules, polyacrylic acid (PAA), cyclic RGD-containing peptides, and proteins (gelatin, collagen, and fibronectin) were successfully immobilized on substrates. After drying the bioglue, targeted biomolecules can still be immobilized on the surfaces preserving their bioactivity. Cell culture on biomolecule-immobilized surfaces using NIH 3T3 fibroblasts and human bone marrow stem cells (hBMSCs) showed significant improvement of cell adhesion and activity compared to the unmodified control in serum-free media after 24 hours. Furthermore, hBMSCs on the fibronectin-immobilized surface showed an increased calcium deposition after 21 days of osteogenic differentiation, suggesting that the immobilized fibronectin is highly bioactive. Given the straightforward protocol and substrate-independent bioglue, the proposed coating strategy is promising in broad-range fields.
Keyphrases
- bone marrow
- stem cells
- ionic liquid
- magnetic nanoparticles
- cell adhesion
- mesenchymal stem cells
- cancer therapy
- capillary electrophoresis
- biofilm formation
- tissue engineering
- randomized controlled trial
- endothelial cells
- type iii
- pseudomonas aeruginosa
- escherichia coli
- gold nanoparticles
- reduced graphene oxide
- cystic fibrosis
- electron transfer
- pluripotent stem cells
- extracellular matrix
- candida albicans